The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects

Sponsor / Institution: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

To study how nicotinamide riboside affects skeletal muscle function in people with heart failure.

Study Design

Single group assignment, open label

Dose

Start at 500mg daily dose (250mg/dose 2x a day) increased at two weekly intervals by 500mg/day to final dose of 1000mg orally 2x a day

Length of Intervention

12 weeks

Intrinsic Capacity

Locomotion

Status

Terminated

Condition or Disease 

Heart Failure

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Locomotion, TerminatedANAD Staff